USHSTAT Trademark
USHSTAT is a USPTO trademark filed by Oxford BioMedica Plc. Status: Cancelled.
Trademark Facts
| Mark | USHSTAT |
|---|---|
| Serial Number | 87807055 |
| Registration Number | 5700940 |
| Status | Cancelled |
| Filing Date | 2018-02-22 |
| Registration Date | 2019-03-19 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT) |
| Owner | Oxford BioMedica Plc |
| Attorney of Record | Roberta S. Bren |
| Prosecution Events | 17 |
| Latest Event | C8.. on 2025-10-03 |
Goods & Services
Enzymes for scientific and research purposes; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science | Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations | Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes | Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products